← SynDRA
hyperin
SynDRA canonical compound SYN0043934 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | AKR1B1 |
|---|
| Mechanism of action | Aldose reductase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Aldose reductase inhibitor
Cross-references
Synonyms
- RefChem:1060998
- MLS000563438
- SMR000232331
- 7-glucosyl-luteolin
- quercetin-hexoside
- NSC-407304
- Quercetin 3-O-.beta.-D-galactopyranoside
- quercetin-O-hexoside
- quercetin-3-hexoside
- hyperin [M+H]+
- quercetin-3-O-hexoside
- Isoquercetin Impurity 1
- HYPEROSIDE (JYPERIN)
- JYPERIN (HYPEROSIDE)
- orb1989768
- SCHEMBL2286562
- BDBM86036
- BDBM513096
- HMS2220K14
- HMS3345A21
- HMS3393B17
- HMS3393H17
- HMS5082A17
- HMS5084H04
- acs.jmedchem.1c00409_ST.693
- CAS_97331
- MFCD00808406
- NSC_97331
- NSC115918
- NSC407304
- AKOS001482436
- AKOS021983639
- CAS_5318390
- NSC_5318390
- DB-051535
- NS00003276
- Quercetin-3-O-glucopyranoside [482-35-9]
- SR-01000721663
- T131681
Look up hyperin in the interactive SynDRA portal →